Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey.
Lizzy Maritza BrewsterPublished in: ESC heart failure (2019)
The life-saving, guideline-recommended, adjunctive therapy for heart failure in African ancestry patients with hydralazine and isosorbide dinitrate is rarely used in Europe. This major evidence-practice gap should urgently be overcome to reduce excess mortality in African-European patients with heart failure.
Keyphrases
- heart failure
- end stage renal disease
- ejection fraction
- newly diagnosed
- healthcare
- left ventricular
- prognostic factors
- primary care
- peritoneal dialysis
- atrial fibrillation
- cardiovascular events
- risk factors
- acute heart failure
- type diabetes
- cardiac resynchronization therapy
- patient reported outcomes
- cross sectional
- coronary artery disease
- genome wide association study
- quality improvement